Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Supply of tocilizumab to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Fresenius Kabi Limited | 02182135 | - | 1 lot Lot 1 | - |
| Roche Products Ltd | 00100674 | - | 1 lot Lot 1 | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
This procurement was divided into 1 lots, each awarded separately. 2 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £28,546,929 initial term | 2 | Fresenius Kabi Limited Roche Products Ltd | complete |
Weightings from the notice.
Government spending data: These suppliers have received £218,201,939 in 4,773 payments (over £25k) from NHS Supply Chain (DHSC-funded), Department of Health and Social Care, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Guy's and St Thomas' NHS FT and 13 more public bodies (2019-10-17 to 2026-03-31).